GamaSTAN .165 g/mL (Immune Globulin (Human) INJECTION, SOLUTION) .165 g/mL

GamaSTAN .165 g/mL is an immune globulin (human) injection used to provide passive immunity. This solution is administered intramuscularly and is manufactured by Grifols USA, LLC.

Strength

.165 g/mL

Pack Size

1 VIAL in 1 CARTON (13533-335-04) / 2 mL in 1 VIAL (13533-335-40)

Manufacturer / TM Owner

GRIFOLS USA, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

GamaSTAN .165 g/mL is primarily used to provide temporary immunity against certain infections. It contains antibodies that can help the body fight off diseases. This product is often used when the immune system is compromised or when immediate protection is needed.

Side Effects

Common effects of GamaSTAN .165 g/mL may include localized reactions at the injection site, such as pain, swelling, or redness. Some individuals may experience mild systemic reactions like headache or fatigue. These effects are generally temporary and resolve on their own.

Precautions & Warnings

GamaSTAN .165 g/mL should be handled with care and administered by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before use. Proper storage and handling are crucial to maintain the efficacy of the solution.

Avoid Interactions

GamaSTAN .165 g/mL may interact with certain medications or substances. It is advisable to consult with a healthcare provider before using this product, especially if you are taking other medications or have underlying health conditions. Alcohol and other substances may also affect the efficacy of the treatment.

Frequently Asked Questions

GamaSTAN .165 g/mL is used to provide temporary immunity against certain infections by delivering antibodies to the body.

GamaSTAN .165 g/mL is administered intramuscularly by a healthcare professional.

Common side effects may include localized reactions at the injection site, such as pain, swelling, or redness, and mild systemic reactions like headache or fatigue.

It is important to consult with a healthcare provider before using GamaSTAN .165 g/mL with other medications to avoid potential interactions.

GamaSTAN .165 g/mL should be stored as per the manufacturer's instructions to maintain its efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.